Hatiora (Rhipsalis baccifera)
Hatiora (Rhipsalis baccifera) is an Amazonian cactus containing flavonoids and phenolic compounds that demonstrate potent anti-inflammatory activity. Research shows its ethanolic stem extract achieved up to 96% inhibition in inflammatory models through mechanisms targeting inflammatory mediator pathways.
Origin & History
Rhipsalis baccifera, also known as mistletoe cactus, is an epiphytic cactus native to Central and South America, the Caribbean, and parts of Florida. It is cultivated for its hanging green stems and bioactive compounds are extracted from these stems using ethanol or pet ether.
Historical & Cultural Context
Rhipsalis baccifera has been noted for its traditional use as a commonly found epiphytic cactus in various regions. It has primarily been cultivated as a low-maintenance ornamental plant, with no specific historical medicinal contexts detailed in the research.
Health Benefits
• Anti-inflammatory effects were observed in a rat paw edema model using ethanolic stem extract, achieving up to 96% inhibition at the higher dose of 200 mg/kg.[2] • The plant contains flavonoids and phenols, which are associated with potential anti-inflammatory properties, though specific mechanisms are not detailed.[1][2] • No acute toxicity was observed in Artemia salina at 100 mg/mL, suggesting a favorable safety profile in initial screenings.[1] • Preclinical evaluations in mice found no major toxicity at studied doses, maintaining normal hematological parameters.[1] • The plant is primarily used as an ornamental houseplant, indicating its safety for general cultivation and handling.[4][5]
How It Works
Hatiora's anti-inflammatory effects are attributed to its flavonoid and phenolic compounds that appear to modulate inflammatory mediator release and reduce edema formation. The ethanolic stem extract likely inhibits cyclooxygenase and lipoxygenase pathways, though specific molecular targets require further investigation. The flavonoids may also scavenge free radicals and reduce pro-inflammatory cytokine production.
Scientific Research
No human clinical trials or meta-analyses have been identified for Rhipsalis baccifera, as per the available sources. Evidence is limited to in vitro and animal studies, with no PMIDs available for human research.
Clinical Summary
Current evidence for Hatiora is limited to preclinical animal studies using rat paw edema models. One study demonstrated dose-dependent anti-inflammatory effects with 200 mg/kg ethanolic stem extract achieving 96% inhibition of inflammation. The research focused on acute inflammatory responses rather than chronic conditions. No human clinical trials have been conducted to establish safety profiles or therapeutic efficacy in humans.
Nutritional Profile
Nutritional macro/micronutrient data for Hatiora (Rhipsalis baccifera) is extremely limited in the literature, as research has focused primarily on its phytochemical and pharmacological properties rather than dietary composition. Known bioactive compounds include: flavonoids (unspecified glycosides and aglycones, concentrations not precisely quantified in published literature) and phenolic compounds (total phenolic content detected in ethanolic stem extracts, contributing to observed antioxidant and anti-inflammatory activity). The plant belongs to the Cactaceae family; like other cacti, stems likely contain mucilaginous polysaccharides (structural carbohydrates), modest fiber content, and high water content typical of succulent tissue. Small berry-like fruits (baccifera = berry-bearing) may contain simple sugars, organic acids, and vitamin C analogous to other Rhipsalis species, though specific concentrations are unquantified. No documented protein, fat, or micronutrient (vitamins/minerals) quantification exists in peer-reviewed sources for this species specifically. Bioavailability of its flavonoid and phenolic constituents is inferred from the demonstrated in vivo anti-inflammatory effect (96% inhibition at 200 mg/kg in rat paw edema model using ethanolic extract), suggesting adequate absorption of active fractions. The ethanolic extraction method implies lipophilic and moderately polar compound recovery; aqueous bioavailability of phenolics may differ.
Preparation & Dosage
Preclinical studies used ethanolic stem extract at 100-200 mg/kg in rats for anti-inflammatory effects. No clinically studied dosages exist for humans. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Curcumin, Boswellia, Ginger, Turmeric, Green tea
Safety & Interactions
Safety data for Hatiora supplementation in humans is currently unavailable due to lack of clinical studies. As with other cactus-derived supplements, potential gastrointestinal upset may occur at higher doses. Drug interactions are unknown but caution is advised when combining with anti-inflammatory medications due to potential additive effects. Pregnant and breastfeeding women should avoid use due to insufficient safety data.